Information about Non-Hodgkin's Lymphoma and Rituxan (Rituximab), the first U.S. approved monoclonal antibody cancer treatment to treat Non-Hodgkin's Lymphoma.
Pharmacy: Drugs and Medications: R: Rituximab: Rituxan - Genentech
Information about Non-Hodgkin's Lymphoma and Rituxan (Rituximab), the first U.S. approved monoclonal antibody cancer treatment to treat Non-Hodgkin's Lymphoma.